Rituximab-ameliorated Cutaneous Extravascular Necrotizing Granuloma. Oka N, Yoshida Y, Sueoka M, Hirata S, et al. Intern Med 2023 Sep 1. doi: 10.2169/internalmedicine.2313.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Oka N, Yoshida Y, Sueoka M, Hirata S, et al. Rituximab-ameliorated Cutaneous Extravascular Necrotizing Granuloma. Intern Med 2023 Sep 1. doi: 10.2169/internalmedicine.2313.
PMID: 37661449